Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Porter

Sports Medicine Hackensack, NJ Medical Doctor

NPI 1871859371 CMS profile 4222924

87 Summit Ave, Hackensack, NJ 07601

Open in the dashboard

General payments

$63,475

161 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,362 paid to institutions, not to them · program year 2024

Through program year 2025, David Porter of Hackensack, NJ is reported in the CMS Open Payments database as having received $63,475 across 161 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $1,362 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 89th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $21,138 21
2024 General $31,666 31
2023 General $1,941 23
2022 General $458 9
2021 General $2,243 33
2020 General $1,226 10
2019 General $4,804 34

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Porter
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to David Porter were reported at $21,138. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year David Porter Sports Medicine median Middle half National median
2019 $4,804 $1,176 $199–$4,249 $163
2020 $1,226 $708 $96–$2,890 $114
2021 $2,243 $1,213 $152–$3,994 $132
2022 $458 $1,230 $159–$3,998 $149
2023 $1,941 $584 $146–$2,836 $160
2024 $31,666 $628 $163–$3,168 $164
2025 $21,138 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Anika Therapeutics, Inc. $52,275 39 payments
  2. SeaPearl Inc $4,402 10 payments
  3. Arthrosurface Incorporated $1,972 8 payments
  4. Stryker Corporation $1,857 31 payments
  5. DePuy Synthes Sales Inc. $1,279 39 payments
  6. Royal Biologics $401 5 payments
  7. Highridge Medical LLC $258 2 payments
  8. Zimvie Inc. $247 2 payments
  9. Smith+Nephew, Inc. $171 7 payments
  10. OSSIO Inc. $165 1 payment
  11. Other $448 17 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $46,500 10 payments
  2. Food and Beverage $8,079 137 payments
  3. Education $4,068 4 payments
  4. Travel and Lodging $2,453 6 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,375 4 payments
Products named General payments · program years 2019–2025
  1. Integrity $30,741 19 payments
  2. Integrity Implant $20,757 11 payments
  3. HemiCAP Shoulder $1,925 8 payments
  4. MAKO $1,108 15 payments
  5. RevoMotion $1,086 5 payments
  6. OVO Motion $1,032 4 payments
  7. Inlay Glenoid 2.0 $1,032 4 payments
  8. GlenoJet $1,032 4 payments
  9. Biomet SpinalPak Non-invasive Spine Fusion Stimulator System $505 4 payments
  10. Tactoset $464 4 payments
  11. Other $4,570 111 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

12

Median for Orthopaedic Surgery: 30

Drug cost

$19

Median for Orthopaedic Surgery: $176

Branded share of claims

0%

Median for Orthopaedic Surgery: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Meloxicam Generic 12 $19

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,233 Part D prescribers listed as Orthopaedic Surgery; they describe a distribution and say nothing about conduct.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
GEMTESA
  • Sumitomo Pharma America, Inc. $38
$38 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

161 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record